Stockreport

Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results

Perspective Therapeutics, Inc.  (CATX) 
PDF SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is [Read more]